About Triomics

Triomics advances oncology research and care operations using its proprietary OncoLLM generative AI technology. The company offers AI-powered platforms that automate clinical trial enrollment, curate complex medical records, and assemble expert-level patient snapshots. Triomics serves top cancer care providers, health systems, and life sciences companies to accelerate research and streamline clinical workflows.

Company Classification

Funding

Customers

Customer	Success Story	Source
Mass General Cancer Center	Implemented Triomics' AI platform to screen every upcoming patient appointment against its entire clinical trial portfolio, delivering daily patient matches directly into providers' workflows.
Medical College of Wisconsin	Early adopter of Triomics' AI platform for matching cancer patients to trials and treatments, conducting a large‑scale empirical evaluation of clinical trial matching using real‑world electronic health records.